Navigation Links
Data Show ARIMIDEX(R) (Anastrozole) Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Breast Cancer
Date:12/14/2007

Effectiveness Of ARIMIDEX Still Evident More Than Three Years After

Treatment

SAN ANTONIO, Texas, Dec. 14 /PRNewswire-FirstCall/ -- Data released today show a continued benefit of ARIMIDEX when compared to tamoxifen in treating postmenopausal women with hormone receptor-positive (HR+) early breast cancer. Results of the ATAC (ARIMIDEX, Tamoxifen, Alone or in Combination) trial, reported today at the 2007 San Antonio Breast Cancer Symposium, represent a median follow-up of more than eight years and show an absolute reduction in the risk of recurrence and distant recurrence with ARIMIDEX. The ATAC trial is one of the world's longest and largest breast cancer studies and is supported by AstraZeneca.

With approximately 2.5 million breast cancer survivors in the United States today, the ATAC 100-month analysis marks a major milestone in understanding the treatment of HR+ early breast cancer(1). The data show that the effects of ARIMIDEX in decreasing the risk of recurrence compared with tamoxifen continue even after patients have completed therapy.

At a median follow-up of 100 months, more than three years after the completion of treatment, ARIMIDEX significantly reduces the risk of recurrence in comparison with tamoxifen in postmenopausal patients with HR+ breast cancer. A significant benefit of ARIMIDEX on distant recurrence is now evident (HR+population p=0.027), and ARIMIDEX is also shown to reduce the risk of distant metastases. Although there was no difference in overall survival, the impact of ARIMIDEX at reducing distant metastases is important, as distant recurrence-free survival is an important predictor for survival related to breast cancer(2).

"The long-term data from the ATAC trial continue to impact the way physicians worldwide treat postmenopausal women with hormone receptor-positive early breast cancer," said Aman U. Buzdar, MD, who represents North America on the ATAC Steering Committe
'/>"/>

SOURCE AstraZeneca
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
2. Battle Continues Over Vietnam PTSD Numbers
3. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
4. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
5. Securians Minnesota Life Continues to Climb Group Life Rankings
6. USA TODAY Continues Spirit of the USA Charity Program as Part of Newspapers 25th Anniversary Celebration
7. United States continues to have highest level of health spending
8. LehmanMillet Continues Expansion with Strategic Hires
9. American Cancer Society report finds breast cancer death rate continues to drop
10. CIGNA HealthCare Continues Gains in Health Care Quality
11. Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 ... overall health, but a growing body of evidence shows the ... finds. In fact, the benefits were similar to those ... Paula Chu, a doctoral candidate at Harvard University,s Health Policy ... found that people randomly assigned to take yoga classes saw ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 Veretekk.com, Inc. ... JM Ocean Avenue. JM Ocean Avenue has secured ... Veretekk online automated marketing system. JM Ocean Avenue ... 2014 merger of Ocean Avenue and JM International, with ... $2 Billion per year company. , “After nearly 2 ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 OutMarket ... today released “ Social Media Cheat Sheets ,” a ... community that drives results on the top ten social ... program. It helps drive awareness, engagement, and customer service. ... marketers to make an impact on new networks and ...
(Date:12/15/2014)... The increase in prevalence of disabling hearing loss ... which is contributing to the growth in the global audiological ... of hearing loss and balance disorders are known as audiological ... speaker and amplifier. The global market is expected to grow ... period from 2014 to 2019. Some of the factors which ...
(Date:12/15/2014)... (PRWEB) December 15, 2014 At the ... organizations AutismOne and Focus Autism ... attendees with research on the effects of toxins to ... and intervention information. , Luminaries such as Dr. ... from abroad with esteemed, credentialed colleagues of the United ...
Breaking Medicine News(10 mins):Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 2Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 3Health News:Audiological Devices Market 2019 Demand for Esthetic Hearing Aids Drives the Growth, Says a Report at ReportsnReports.com 4Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... often to blame, study finds , WEDNESDAY, Nov. 7 ... known to be effective, many patients stop taking them, ... to blame. , In their study, researchers in Chicago ... statin discontinuation rates among more than 768,000 patients were ...
... Bowen,Foundation,s inaugural ,Cruise to Cure Autism, will launch on ... Marina located at 410,Severn Avenue in Eastport. The fundraising ... address autism in Maryland and describe the,education and resources ... is one of the fastest growing diagnoses we see ...
... formula for cats and dogs, ROCKPORT, Maine, Nov. ... health in humans, are good for pets too! That,s ... town of,Rockport, has introduced OmegaMaine Pet(TM), a human-grade omega-3 ... omega-3 oil on the,market for pets. Most omega-3 oils ...
... Gaps in ... Breast Cancer Care, Survival, JACKSON, Miss., Nov. 7 ... G. Komen for the Cure will,host a public forum to launch ... events mark the,fifteenth stop of a 25-city campaign to elevate breast ...
... Inc., a national healthcare,management and technology company, ... to provide Revenue Cycle Management (RCM), ASP,Practice ... services. Molina Healthcare of California is ... patients who have traditionally faced barriers,to quality ...
... is an Op-Ed,by David W. Gorman, Washington Headquarters Executive ... will praise the 30,000 troops "officially,wounded" in action in ... of "fact." In doing so, they,ll harm the men ... in today,s very dangerous world., That 30,000 number ...
Cached Medicine News:Health News:Many Patients Stop Taking Cholesterol-Lowering Drugs 2Health News:Maine Natural Health Company Brings Omega-3 Benefits to Pets 2Health News:Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Legislators, Health Officials, Breast Cancer Survivors and Activists Call for Action on Breast Cancer 2Health News:Molina Medical Group Selects MED3OOO 2Health News:Shape Shifting on Veterans Day 2
(Date:12/15/2014)... Dec. 15, 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... been added to the NASDAQ Biotechnology Index (NBI). ... become effective upon market open on December 22, ... designed to track the performance of a set ... biotechnology or pharmaceutical according to the Industry Classification ...
(Date:12/15/2014)... 15, 2014  Colorado and Washington State ... use of cannabis. Oregon , ... ended prohibition during the November 2014 elections. ... http://photos.prnewswire.com/prnh/20141212/164153LOGO The benefits of legalizing cannabis ... benefits like the increased tax revenue for state and local ...
(Date:12/15/2014)... MEADOWS, N.Y. , Dec. 15, 2014 ... the SPL (Structured Product Labeling) markup language standard, content ... the understanding and skills to work with the standard. ... a series of three webinars on the benefits and ... three one-hour webinars will be facilitated by Howard ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3
... , CARY, N.C., Dec. 18 Cornerstone Therapeutics ... acquiring, developing and commercializing significant products primarily for the respiratory ... conference call at 8:30 AM ET on Thursday, January 7, ... intends to issue a press release outlining its financial guidance ...
... , WASHINGTON, Dec. 18 ... "Help is Here Express" bus tour visited Jacksonville Beach,s Mission ... programs that provide prescription medicines for free or nearly free. , ... helping the needy and poor. , The "Help is Here Express" ...
Cached Medicine Technology:Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 2Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 3Prescription Assistance Arrives in Jacksonville, Florida 2
...
...
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
Medicine Products: